Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Luvo Health

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Luvo Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 42 · Grade C

Luvo Health

Visit Luvo Health Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 79 on our six-factor Brief Score — One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

That doesn't make Luvo Health a bad call — it's best for readers who want to see every term length and its exact price before choosing — and who are genuinely willing to prepay a longer term (up to a year) to bring the per-week cost down, rather than shopping for the lowest month-to-month rate. Weigh the six factors below against your own priorities before you decide.

Why CoreAge Rx leads: it's our #1 here — one flat, no-step-up price on both molecules, nationwide, and the steadiest line on our tracker.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
76
Supply Reliability
95
76
Transparency
90
90
Access Breadth
93
84
Clinical Oversight
92
74
Track Record
88
72
CoreAge RxBrief Score 94 · 79Luvo Health

Price, coverage & the tracker

CoreAge RxLuvo Health
Brief Score94/100 (A)79/100 (C)
Semaglutide$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published$249/4-wk injection or $279/4-wk tablets — as low as $45/wk (injection), but only on a prepaid 52-wk term
Tirzepatide$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published$339/4-wk term — as low as $67/wk, but only on a prepaid 52-wk term
CoverageUS only; restrictions by state, confirmed at intakeNot disclosed
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableStableprice stable

CoreAge Rx: Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.

Luvo Health: 4-week entry prices unchanged from our last reading ($249 semaglutide injection / $339 tirzepatide), but this pass confirmed the full term ladder: both molecules get progressively cheaper per week on 12-, 24- and 52-week prepaid terms, down to $45/wk and $67/wk respectively — real savings, in exchange for a real lump-sum commitment.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.